{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:23:24Z","timestamp":1790519004331,"version":"4.1.0"},"reference-count":37,"publisher":"Japanese Circulation Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1253\/circj.cj-17-0877","type":"journal-article","created":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T22:18:53Z","timestamp":1522707533000},"page":"1396-1404","source":"Crossref","is-referenced-by-count":52,"title":["Apolipoprotein A-1 Binding Protein Inhibits Inflammatory Signaling Pathways by Binding to Apolipoprotein A-1 in THP-1 Macrophages"],"prefix":"10.1253","volume":"82","author":[{"given":"Min","family":"Zhang","sequence":"first","affiliation":[{"name":"Institute of Cardiovascular Disease, Key Lab for Atherosclerology of Hunan Province, Medicine Research Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Jun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Guilin Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yin","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Disease, Key Lab for Atherosclerology of Hunan Province, Medicine Research Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dan","family":"Xia","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Disease, Key Lab for Atherosclerology of Hunan Province, Medicine Research Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duo","family":"Gong","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Disease, Key Lab for Atherosclerology of Hunan Province, Medicine Research Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Wang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Disease, Key Lab for Atherosclerology of Hunan Province, Medicine Research Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Yan","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Disease, Key Lab for Atherosclerology of Hunan Province, Medicine Research Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Long","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, The Libin Cardiovascular Institute of Alberta, The University of Calgary, Health Sciences Center"},{"name":"Key Laboratory of Molecular Targets & Clinical Pharmacology, School of Pharmaceutical Sciences, Guangzhou Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Er","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Shaoyang University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Ke","family":"Tang","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Disease, Key Lab for Atherosclerology of Hunan Province, Medicine Research Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Yu XH, Fu YC, Zhang DW, Yin K, Tang CK. Foam cells in atherosclerosis. <i>Clin Chim Acta<\/i> 2013; 424: 245\u2013252.","DOI":"10.1016\/j.cca.2013.06.006"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: A dynamic balance. <i>Nat Rev Immunol<\/i> 2013; 13: 709\u2013721.","DOI":"10.1038\/nri3520"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Huang L, Fan B, Ma A, Shaul PW, Zhu H. Inhibition of ABCA1 protein degradation promotes HDL cholesterol efflux capacity and RCT and reduces atherosclerosis in mice. <i>J Lipid Res<\/i> 2015; 56: 986\u2013997.","DOI":"10.1194\/jlr.M054742"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ogura M, Ayaori M, Terao Y, Hisada T, Iizuka M, Takiguchi S, et al. Proteasomal inhibition promotes ATP-binding cassette transporter A1 (ABCA1) and ABCG1 expression and cholesterol efflux from macrophages in vitro and in vivo. <i>Arterioscler Thromb Vasc Biol<\/i> 2011; 31: 1980\u20131987.","DOI":"10.1161\/ATVBAHA.111.228478"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Zhao GJ, Yin K, Fu YC, Tang CK. The interaction of ApoA-I and ABCA1 triggers signal transduction pathways to mediate efflux of cellular lipids. <i>Mol Med<\/i> 2012; 18: 149\u2013158.","DOI":"10.2119\/molmed.2011.00183"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Yin K, Tang SL, Yu XH, Tu GH, He RF, Li JF, et al. Apolipoprotein A-I inhibits LPS-induced atherosclerosis in ApoE(\u2212\/\u2212) mice possibly via activated STAT3-mediated upregulation of tristetraprolin. <i>Acta Pharmacol Sin<\/i> 2013; 34: 837\u2013846.","DOI":"10.1038\/aps.2013.10"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lv YC, Tang Y, Zhang P, Wan W, Yao F, He P, et al. Histone methyltransferase enhancer of zeste homolog 2-mediated ABCA1 promoter DNA methylation contributes to the progression of atherosclerosis. <i>PLoS One<\/i> 2016; 11: e157265.","DOI":"10.1371\/journal.pone.0157265"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Yin K, You Y, Swier V, Tang L, Radwan MM, Pandya AN, et al. Vitamin D protects against atherosclerosis via regulation of cholesterol efflux and macrophage polarization in hypercholesterolemic swine. <i>Arterioscler Thromb Vasc Biol<\/i> 2015; 35: 2432\u20132442.","DOI":"10.1161\/ATVBAHA.115.306132"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ito A, Hong C, Rong X, Zhu X, Tarling EJ, Hedde PN, et al. LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling. <i>Elife<\/i> 2015; 4: e8009.","DOI":"10.7554\/eLife.08009"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Soro-Paavonen A, Westerbacka J, Ehnholm C, Taskinen MR. Metabolic syndrome aggravates the increased endothelial activation and low-grade inflammation in subjects with familial low HDL. <i>Ann Med<\/i> 2006; 38: 229\u2013238.","DOI":"10.1080\/07853890500526352"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ritter M, Buechler C, Boettcher A, Barlage S, Schmitz-Madry A, Orso E, et al. Cloning and characterization of a novel apolipoprotein A-I binding protein, AI-BP, secreted by cells of the kidney proximal tubules in response to HDL or ApoA-I. <i>Genomics<\/i> 2002; 79: 693\u2013702.","DOI":"10.1006\/geno.2002.6761"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Zhang M, Li L, Xie W, Wu JF, Yao F, Tan YL, et al. Apolipoprotein A-1 binding protein promotes macrophage cholesterol efflux by facilitating apolipoprotein A-1 binding to ABCA1 and preventing ABCA1 degradation. <i>Atherosclerosis<\/i> 2016; 248: 149\u2013159.","DOI":"10.1016\/j.atherosclerosis.2016.03.008"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Fang L, Choi SH, Baek JS, Liu C, Almazan F, Ulrich F, et al. Control of angiogenesis by AIBP-mediated cholesterol efflux. <i>Nature<\/i> 2013; 498: 118\u2013122.","DOI":"10.1038\/nature12166"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sultana A, Cochran BJ, Tabet F, Patel M, Torres LC, Barter PJ, et al. Inhibition of inflammatory signaling pathways in 3T3-L1 adipocytes by apolipoprotein A-I. <i>FASEB J<\/i> 2016; 30: 2324\u20132335.","DOI":"10.1096\/fj.201500026R"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kim KN, Ko SC, Ye BR, Kim MS, Kim J, Ko EY, et al. 5-Bromo-2-hydroxy-4-methyl- benzaldehyde inhibited LPS-induced production of pro-inflammatory mediators through the inactivation of ERK, p38, and NF-kappaB pathways in RAW 264.7 macrophages. <i>Chem Biol Interact<\/i> 2016; 258: 108\u2013114.","DOI":"10.1016\/j.cbi.2016.08.022"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Zhang X, Li N, Shao H, Meng Y, Wang L, Wu Q, et al. Methane limit LPS-induced NF-kappaB\/MAPKs signal in macrophages and suppress immune response in mice by enhancing PI3K\/AKT\/GSK-3\u03b2-mediated IL-10 expression. <i>Sci Rep<\/i> 2016; 6: 29359.","DOI":"10.1038\/srep29359"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Abate W, Alghaithy AA, Parton J, Jones KP, Jackson SK. Surfactant lipids regulate LPS-induced interleukin-8 production in A549 lung epithelial cells by inhibiting translocation of TLR4 into lipid raft domains. <i>J Lipid Res<\/i> 2010; 51: 334\u2013344.","DOI":"10.1194\/jlr.M000513"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Schoeniger A, Fuhrmann H, Schumann J. LPS- or Pseudomonas aeruginosa-mediated activation of the macrophage TLR4 signaling cascade depends on membrane lipid composition. <i>PeerJ<\/i> 2016; 4: e1663.","DOI":"10.7717\/peerj.1663"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Jang SE, Hyam SR, Jeong JJ, Han MJ, Kim DH. Penta-O-galloyl-beta-D-glucose ameliorates inflammation by inhibiting MyD88\/NF-kappaB and MyD88\/MAPK signalling pathways. <i>Br J Pharmacol<\/i> 2013; 170: 1078\u20131091.","DOI":"10.1111\/bph.12333"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Fessler MB, Parks JS. Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling. <i>J Immunol<\/i> 2011; 187: 1529\u20131535.","DOI":"10.4049\/jimmunol.1100253"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Taleb S. Inflammation in atherosclerosis. <i>Arch Cardiovasc Dis<\/i> 2016; 109: 708\u2013715.","DOI":"10.1016\/j.acvd.2016.04.002"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Viola J, Soehnlein O. Atherosclerosis: A matter of unresolved inflammation. <i>Semin Immunol<\/i> 2015; 27: 184\u2013193.","DOI":"10.1016\/j.smim.2015.03.013"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Mendel I, Yacov N, Harats D, Breitbart E. Therapies targeting innate immunity for fighting inflammation in atherosclerosis. <i>Curr Pharm Des<\/i> 2015; 21: 1185\u20131195.","DOI":"10.2174\/1381612820666141013133322"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Murphy AJ, Woollard KJ, Hoang A, Mukhamedova N, Stirzaker RA, McCormick SP, et al. High-density lipoprotein reduces the human monocyte inflammatory response. <i>Arterioscler Thromb Vasc Biol<\/i> 2008; 28: 2071\u20132077.","DOI":"10.1161\/ATVBAHA.108.168690"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Moghimpour BF, Vallejo JG, Rezaei N. Toll-like receptor signaling pathways in cardiovascular diseases: Challenges and opportunities. <i>Int Rev Immunol<\/i> 2012; 31: 379\u2013395.","DOI":"10.3109\/08830185.2012.706761"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Zhang Y, Chen F, Chen J, Huang S, Chen J, Huang J, et al. Soyasaponin Bb inhibits the recruitment of toll-like receptor 4 (TLR4) into lipid rafts and its signaling pathway by suppressing the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-dependent generation of reactive oxygen species. <i>Mol Nutr Food Res<\/i> 2016; 60: 1532\u20131543.","DOI":"10.1002\/mnfr.201600015"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Das S, Alhasson F, Dattaroy D, Pourhoseini S, Seth RK, Nagarkatti M, et al. NADPH oxidase-derived peroxynitrite drives inflammation in mice and human nonalcoholic steatohepatitis via TLR4-lipid raft recruitment. <i>Am J Pathol<\/i> 2015; 185: 1944\u20131957.","DOI":"10.1016\/j.ajpath.2015.03.024"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Pamukcu B, Lip GY, Shantsila E. The nuclear factor--kappa B pathway in atherosclerosis: A potential therapeutic target for atherothrombotic vascular disease. <i>Thromb Res<\/i> 2011; 128: 117\u2013123.","DOI":"10.1016\/j.thromres.2011.03.025"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Li Q, Verma IM. NF-kappaB regulation in the immune system. <i>Nat Rev Immunol<\/i> 2002; 2: 725\u2013734.","DOI":"10.1038\/nri910"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Sun SC. The non-canonical NF-kappaB pathway in immunity and inflammation. <i>Nat Rev Immunol<\/i> 2017; 17: 545\u2013558.","DOI":"10.1038\/nri.2017.52"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Muslin AJ. MAPK signalling in cardiovascular health and disease: Molecular mechanisms and therapeutic targets. <i>Clin Sci (Lond)<\/i> 2008; 115: 203\u2013218.","DOI":"10.1042\/CS20070430"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Westerterp M, Bochem AE, Yvan-Charvet L, Murphy AJ, Wang N, Tall AR. ATP-binding cassette transporters, atherosclerosis, and inflammation. <i>Circ Res<\/i> 2014; 114: 157\u2013170.","DOI":"10.1161\/CIRCRESAHA.114.300738"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Tang C, Liu Y, Kessler PS, Vaughan AM, Oram JF. The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor. <i>J Biol Chem<\/i> 2009; 284: 32336\u201332343.","DOI":"10.1074\/jbc.M109.047472"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Tang C, Houston BA, Storey C, LeBoeuf RC. Both STAT3 activation and cholesterol efflux contribute to the anti-inflammatory effect of apoA-I\/ABCA1 interaction in macrophages. <i>J Lipid Res<\/i> 2016; 57: 848\u2013857.","DOI":"10.1194\/jlr.M065797"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Yin K, Chen WJ, Zhou ZG, Zhao GJ, Lv YC, Ouyang XP, et al. Apolipoprotein A-I inhibits CD40 proinflammatory signaling via ATP-binding cassette transporter A1-mediated modulation of lipid raft in macrophages. <i>J Atheroscler Thromb<\/i> 2012; 19: 823\u2013836.","DOI":"10.5551\/jat.12823"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Liu D, Ding Z, Wu M, Xu W, Qian M, Du Q, et al. The apolipoprotein A-I mimetic peptide, D-4F, alleviates ox-LDL-induced oxidative stress and promotes endothelial repair through the eNOS\/HO-1 pathway. <i>J Mol Cell Cardiol<\/i> 2017; 105: 77\u201388.","DOI":"10.1016\/j.yjmcc.2017.01.017"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Wu BJ, Ong KL, Shrestha S, Chen K, Tabet F, Barter PJ, et al. Inhibition of arthritis in the Lewis rat by apolipoprotein A-I and reconstituted high-density lipoproteins. <i>Arterioscler Thromb Vasc Biol<\/i> 2014; 34: 543\u2013551.","DOI":"10.1161\/ATVBAHA.113.302832"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/82\/5\/82_CJ-17-0877\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T22:50:05Z","timestamp":1571007005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/82\/5\/82_CJ-17-0877\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-17-0877","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}